Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.650
-0.005 (-0.76%)
At close: Dec 5, 2025, 4:00 PM EST
0.659
+0.009 (1.38%)
After-hours: Dec 5, 2025, 7:59 PM EST
Plus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -20.58 | -12.98 | -13.32 | -20.28 | -13.4 | -8.24 | Upgrade
|
| Depreciation & Amortization | 0.5 | 0.72 | 0.63 | 0.71 | 0.42 | 0.37 | Upgrade
|
| Other Amortization | - | 0.02 | 0.19 | 0.39 | 0.55 | 0.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | - | 0 | - | 0.07 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.09 | 0.13 | 0.12 | - | 0.25 | 0.78 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.06 | -0.11 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.96 | 0.55 | 0.57 | 0.61 | 0.61 | 0.25 | Upgrade
|
| Other Operating Activities | 5.69 | -2.11 | 0.08 | -0 | -0.01 | -2.29 | Upgrade
|
| Change in Accounts Receivable | -0.57 | -0.57 | - | - | - | 1.17 | Upgrade
|
| Change in Accounts Payable | -2.93 | 4.7 | -3.68 | 6.45 | 1.73 | -1.23 | Upgrade
|
| Change in Unearned Revenue | 1.13 | -1 | 0.28 | 1.64 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.06 | 0.09 | 2.28 | -2.5 | -0.5 | 0.18 | Upgrade
|
| Operating Cash Flow | -15.73 | -10.55 | -12.85 | -12.97 | -10.28 | -8.43 | Upgrade
|
| Capital Expenditures | -0.05 | -0.15 | -0.16 | -0.51 | -0.14 | -0.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | - | - | - | 0.06 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.01 | -0.55 | - | -0.25 | - | -0.4 | Upgrade
|
| Investment in Securities | 0.31 | -3.42 | - | - | - | - | Upgrade
|
| Investing Cash Flow | 0.29 | -4.11 | -0.16 | -0.76 | -0.08 | -0.49 | Upgrade
|
| Short-Term Debt Issued | - | 3.29 | - | - | - | - | Upgrade
|
| Total Debt Issued | 3.74 | 3.29 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -4 | -1.61 | -1.61 | -0.28 | -5.42 | Upgrade
|
| Net Debt Issued (Repaid) | -3.26 | -0.7 | -1.61 | -1.61 | -0.28 | -5.42 | Upgrade
|
| Issuance of Common Stock | 35.54 | 7.27 | 5.53 | 15.83 | 20.69 | 5.11 | Upgrade
|
| Repurchase of Common Stock | - | -0.37 | -0.13 | - | - | - | Upgrade
|
| Other Financing Activities | -4.77 | - | -0.35 | -0.77 | - | - | Upgrade
|
| Financing Cash Flow | 27.51 | 6.19 | 3.45 | 13.45 | 20.42 | -0.32 | Upgrade
|
| Net Cash Flow | 12.07 | -8.48 | -9.57 | -0.28 | 10.05 | -9.25 | Upgrade
|
| Free Cash Flow | -15.78 | -10.7 | -13.01 | -13.48 | -10.42 | -8.53 | Upgrade
|
| Free Cash Flow Margin | -300.06% | -183.72% | -264.83% | -6018.30% | - | -2814.19% | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -1.39 | -4.14 | -7.70 | -12.93 | -28.89 | Upgrade
|
| Cash Interest Paid | 0.54 | 0.03 | 0.22 | 0.33 | 0.39 | 0.57 | Upgrade
|
| Levered Free Cash Flow | -9.36 | -3.48 | -8.43 | -8.21 | -5.18 | -5.13 | Upgrade
|
| Unlevered Free Cash Flow | -8.98 | -3.39 | -8.37 | -8.15 | -5.14 | -5.03 | Upgrade
|
| Change in Working Capital | -2.31 | 3.22 | -1.12 | 5.6 | 1.24 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.